Graves' disease triggered by autoinfarction of an autonomously functioning thyroid adenoma

Journal of Nuclear Medicine

Volumn 38, Issue 2, 1997, Pages 260-262

  Gallegos, Elizabeth ^b   Meier, Donald A ^a   Garcia, Michael ^b  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

^b NONE

Author keywords

autoinfarction; autonomously functioning thyroid adenoma; Graves' disease

Indexed keywords

ADULT; ARTICLE; CASE REPORT; FEMALE; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; IMAGE ANALYSIS; PRIORITY JOURNAL; THYROID ADENOMA; THYROID FUNCTION; THYROID FUNCTION TEST;

ADENOMA; ADULT; FEMALE; GRAVES DISEASE; HUMANS; HYPERTHYROIDISM; INFARCTION; IODINE RADIOISOTOPES; SODIUM PERTECHNETATE TC 99M; THYROID NEOPLASMS;

EID: 0031046282     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Meier DA, Dworkin HJ. The autonomously functioning thyroid nodule [Editorial]. J Nucl Med 1991;32:20-32.
2. Miller JM, Horn RC, Block MA. The autonomous functioning thyroid nodule in the evaluation of nodular goiter. J Clin Endocrinol Metab 1967;27:1264.
3. Paschke R, Tonacchera M, VanSande J, Parma J, Vassart G. Identification and functional characterization of two new somatic mutations causing constitutive activation of the thyrotropin receptor in hyperfunctioning autonomous adenomas of the thyroid. J Clin Endocrinol Metab 1994;79:1785-1789.
4. Russo D, Arturi F, Wicker R, et al. Genetic alterations in thyroid hyperfunctioning adenomas. J Clin Endocrinol Metab 1995;80:1347-1351.
5. Russo D, Arturi F, Suarez H, et al. Thyrotropin receptor gene alterations in thyroid hyperfunctioning adenomas. J Clin Endocrinol Metab 1996;81:1548-1551.
6. Hamburger JI. Evolution of toxicity in solitary nontoxic autonomously functioning thyroid nodules. J Clin Endocrinol Metab 1980;50:1089.
7. Hamburger JI, Taylor CI. Transient thyrotoxicosis associated with acute hemorrhagic infarction of autonomously functioning thyroid nodules. Ann Intern Med 1979;91: 406-409.
8. Grubeck-Loebenstein B, Derfler K, Kassal H, et al. Immunological features of nonimmunogenic hyperthyroidism. J Clin Endocrinol Metab 1985;60:150.
9. Sellschopp C, Derwahl M, Schaube H, Hamelmann H. Evidence of autoimmune pathogenesis in autonomous thyroid adenoma. Acta Endocrinol (Copenh) 1987;281; 355-357.
10. Bendezu R, Wieland G, Tang P, Levine B. Unusual events preceding hyperthyroidism with diffuse goiter. Arch Intern Med 1997; 137;1023-1025.
11. Boddenberg B, Voth E, Schicha H. Immunogenic hyperthyroidism following radioiodine ablation of a focal autonomy. Nuclearmedizin 1993;32;18-22.
12. Smyth PPA, Neylan D, McMullan NM, Smith DF, McKenna TJ. Sequential presentation of a case of hyperthyroidism with autonomously functioning nodules and Graves' disease in the presence of IgG thyroid stimulators. Acta Endocrinologica (Copenh) 1988;118:474-478.
13. Chiovato L, Santini F, Vitti P, Bendinelli G, Pinchera A. Appearance of thyroid stimulating antibody and Graves' disease after radioiodine therapy for toxic nodular goitre. Clin Endocrinol 1991;40:803-806.